Stock PAX PAXMAN AB
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Paxman AB

Equities

PAX

SE0009806284

Market Closed - Nasdaq Stockholm
Other stock markets
 08:33:50 20/05/2024 pm IST 		5-day change 1st Jan Change
40 SEK 0.00% Intraday chart for Paxman AB 0.00% +8.70%
15/01 Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy
CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Paxman AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Paxman Scalp Cooling System Receives EU MDR Certification
CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Paxman AB Announces Its Selection by the SWOG Cancer Research Network for the Paxman Limb Cryocompression System to Be Used in A Prospectively Designed Study Looking At Prevention of Chemotherapy-Induced Peripheral Neuropathy
CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Paxman Launches Enhanced Provider and Patient Assistance Services, as Well as Offering A New Business Model to Health Systems
CI
Paxman AB Signs Letter of Interest with Guangzhou Concord Medical Sci-Tech Innovation Center Co. Ltd. to Enter into Distribution and Marketing Agreement
CI
Paxman AB Signs New Distribution Agreement with Partner in Serbia
CI
Paxman AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Paxman AB Announces Nelson Arcos S.A. as Their Global Distribution Partner for Paxman Equipment in Uruguay
CI
Paxman opens CIPN Clinical Trial with National University Hospital, Singapore
CI
Paxman AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAX Stock
  4. News Paxman AB
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW